Seizert Capital Partners LLC Acquires Shares of 16,385 Tactile Systems Technology, Inc. (NASDAQ:TCMD)

Seizert Capital Partners LLC acquired a new stake in shares of Tactile Systems Technology, Inc. (NASDAQ:TCMD) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 16,385 shares of the company’s stock, valued at approximately $281,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Jones Financial Companies Lllp purchased a new stake in Tactile Systems Technology during the fourth quarter valued at approximately $39,000. Gladius Capital Management LP bought a new position in Tactile Systems Technology in the third quarter worth approximately $44,000. XTX Topco Ltd bought a new position in Tactile Systems Technology in the third quarter worth approximately $163,000. Retireful LLC bought a new position in Tactile Systems Technology in the fourth quarter worth approximately $173,000. Finally, Victory Capital Management Inc. bought a new position in Tactile Systems Technology in the third quarter worth approximately $180,000. 83.43% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Tactile Systems Technology

In other news, Director Daniel L. Reuvers sold 10,938 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $14.55, for a total transaction of $159,147.90. Following the completion of the sale, the director now owns 242,942 shares in the company, valued at approximately $3,534,806.10. This represents a 4.31 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Elaine M. Birkemeyer sold 3,778 shares of the stock in a transaction on Monday, February 24th. The shares were sold at an average price of $14.70, for a total value of $55,536.60. Following the sale, the chief financial officer now owns 104,098 shares of the company’s stock, valued at approximately $1,530,240.60. This represents a 3.50 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 19,546 shares of company stock valued at $285,444. 0.96% of the stock is currently owned by corporate insiders.

Tactile Systems Technology Stock Up 1.2 %

Shares of NASDAQ TCMD opened at $14.20 on Thursday. The company has a current ratio of 4.36, a quick ratio of 3.80 and a debt-to-equity ratio of 0.11. The stock has a market capitalization of $334.91 million, a PE ratio of 20.29 and a beta of 1.20. The stock’s fifty day simple moving average is $16.79 and its two-hundred day simple moving average is $15.77. Tactile Systems Technology, Inc. has a 12-month low of $11.12 and a 12-month high of $21.10.

Tactile Systems Technology (NASDAQ:TCMD) last announced its earnings results on Tuesday, February 18th. The company reported $0.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.31 by $0.09. The business had revenue of $85.59 million for the quarter, compared to analysts’ expectations of $85.39 million. Tactile Systems Technology had a return on equity of 9.37% and a net margin of 5.79%. As a group, analysts expect that Tactile Systems Technology, Inc. will post 0.7 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on TCMD shares. StockNews.com cut Tactile Systems Technology from a “strong-buy” rating to a “buy” rating in a research note on Thursday, January 16th. B. Riley cut Tactile Systems Technology from a “buy” rating to a “neutral” rating and dropped their price objective for the stock from $23.00 to $18.00 in a research note on Wednesday, February 19th.

Tactile Systems Technology Profile

Tactile Systems Technology, Inc, a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers.